Ginolis has undergone a significant internal transformation, prompting a strategic reassessment of our brand identity to align with our current operation and customer segments. This evolution has strengthened our position in the market and enabled us to meet our customers’ evolving needs.
Ginolis is pleased to announce the appointment of Chris Buhlmann as our General Manager for North America.
BBI Solutions chose Ginolis BBI Solutions has served the global diagnostics industry for over 50 years, as a leading developer and manufacturer of raw materials and
Kauko Väinämö has been appointed as CEO of Ginolis Oy from September 1, 2022. Kauko has more than 30 years of solid knowledge in strategic leadership, having
A global pandemic presents many challenges for diagnostic device manufacturers, especially those dependent on traditional manufacturing processes that are not conducive to the social distancing
Ginolis Ltd. and CELLINK AB have entered into an agreement where CELLINK acquires 100 per cent of Ginolis shares. With this acquisition, Ginolis will be